A. Lloyd, R. Kennedy, J. Hutchinson, and W. Sawyer, Economic evaluation of highly purified menotropin compared with recombinant follicle-stimulating hormone in assisted reproduction, Fertility and Sterility, vol.80, issue.5, pp.1108-1121, 2003.
DOI : 10.1016/S0015-0282(03)02185-X

F. Lorusso, M. Palmisano, G. Serratì, E. Bassi, G. Lamanna et al., Intrauterine insemination with recombinant or urinary human chorionic gonadotropin: A prospective randomized trial, Gynecological Endocrinology, vol.68, issue.11, pp.24-644, 2008.
DOI : 10.1016/j.fertnstert.2006.11.025

F. Olivennes and R. Frydman, Assistance médicale à la procréation, 3ème édition, MASSON. p 3 à 9, 13 à 52,56 à 59, pp.94-95, 2006.

M. Van-wely, I. Kwan, A. Burt, J. Thomas, A. Vail et al., Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles, Cochrane Database Syst Rev, vol.22, issue.5, 2011.
DOI : 10.1002/14651858.CD005354.pub2